Meeting Reports (Ethics)Journal of Pharmacology and PharmacotherapeuticsVol. 11 | Issue 4 | 2021 | pp. 142–144Open access
Scenarios in Medical Ethics-1: Composition and Functioning of Ethics Committees
- 1,
- 1*,
- 1
- 1 Department of Pharmacology, JIPMER, Pondicherry, India.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: Jayanthi Mathaiyan
Department of Pharmacology, JIPMER, Pondicherry, India.
Email: drjayanthi2008@gmail.com
Copyright: © 2021 Manuscript Technomedia LLP. This is an open access article.
- Published:
- May 14, 2021
- Received:
- Dec 24, 2020
- Accepted:
- Dec 29, 2020
How to cite
Natarajan, H., Mathaiyan, J., & Ramasamy, R. (2021). Scenarios in Medical Ethics-1: Composition and Functioning of Ethics Committees. Journal of Pharmacology and Pharmacotherapeutics, 11(4), 142–144. https://doi.org/10.4103/jpp.jpp_171_20
Abstract
A bioethics training workshop for Institutional Ethics Committee (IEC) members was organized on 16th–17th September 2019 at Jawaharlal Institute of Postgraduate Medical Education and Research, Puducherry in South India in association with Indian Council of Medical Research (ICMR) Bioethics Unit, Bangalore, India. It was attended by eighty delegates from 18 institutions. ICMR bioethics unit at Bangalore has been actively involved in educating Indian researchers on medical research ethics since the latest version of the guidelines “National Ethical Guidelines for Biomedical and Health Research” has been released in 2017. The workshop was planned to train IEC members on the ICMR Ethical guidelines for biomedical research on human participants 2017 as well as the New Drugs and Clinical Trials (NDCT) rules 2019 in addition to having topics of recent relevance such as stem cell research, vaccine research, public health research, and IEC registration and accreditation. The workshop consisted of six-panel discussion sessions. In a variation from the usual ethics workshops, we planned each session to have a lecture followed by case discussions. Each session included a series of 3–6 scenarios followed by 1–3 questions. After presenting each scenario, the participants were invited to give their comments. After a thorough discussion, a set of panelists, who were experts in biomedical ethics, were invited to discuss the scenario and provide more informed and authoritative opinions. The discussions were quite lively and we believe that the case scenarios should be of wider interest. In this piece, we discuss the first-panel discussion on “Composition and functioning of ethics committees.” The answers provided by the participants are listed first followed by the expert opinion by the panelists.
Subject
Article metadata
| Title | Scenarios in Medical Ethics-1: Composition and Functioning of Ethics Committees |
|---|---|
| Authors | Harivenkatesh Natarajan; Jayanthi Mathaiyan; Raveendran Ramasamy |
| Affiliations | Department of Pharmacology, JIPMER, Pondicherry, India. |
| Corresponding author | drjayanthi2008@gmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 11, Issue 4 (2021) |
Also in this issue
- Adaptive Designs in Clinical Trialspp. 129–133
- Comparison of Topical Ivermectin and Oral Ivermectin in the Treatment of Human Scabies: A Randomized Controlled Trialpp. 134–139
- Late-Onset Clozapine-Induced Agranulocytosis in a Young Woman with Paranoid Schizophreniapp. 140–141
- Scenarios in Medical Ethics 2: Challenges for Ethics Committeespp. 145–147
- Scenarios in Medical Ethics-3: New Drugs and Clinical Trials Rules 2019pp. 148–150
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026